entertainment -WSS

entertainment

author：comprehensive 2025-09-28 23:49:36 - browse：9

What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a singular regulator?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We explain the debate over Vertex Pharmaceuticals’ novel pain drug, whose success in clinical trials comes with a sizable caveat. We also talk about the latest news in the life sciences, including an epitaph for Aduhelm and the retirement of an FDA icon.

For more on what we cover, here’s the news on Vertex; here’s more on Aduhelm; here’s the exit interview with Janet Woodcock; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Eyeing GLP

focus

WSS

Do more moles mean more problems? Not so, says new study

Startling documents reveal new facets of Sacklers' opioid empire

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Adam's Biotech Scorecard: Do Sarepta's exon

H5N1 virus can be tracked in retail milk, scientists say

entertainment

entertainment

entertainment

How one medical school became remarkably diverse

For longer

United colonoscopy coverage change 'may cost lives,' doctors say

What will save rural psychiatry services? Higher Medicaid payments

In Memoriam: Notable people who died in 2023

As a primary care physician, here's how I hope to partner with AI

Anesthesiologist group: stop taking Ozempic before surgery

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

23andMe had bad news about my health. I wish a person had delivered it

Focused ultrasound for uterine fibroids: an uphill battle

leisure time

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Prosthetic arm enables patients to feel the objects they grip

Lab trade group sues FDA to halt regulation of lab

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Heat waves linked to early deliveries, preterm births in new study

Reports of telehealth's death have been greatly exaggerated

focus

leisure time

focus

leisure time